Nanjing YDB Medical Technology Co., Ltd. was established in October 2013 with a registered capital of 100 million yuan. The company is located in Nanjing Gaochun Economic Development Zone and specializes in providing high-end medical devices for cardiovascular, peripheral vascular, and neurovascular interventions. The company integrates research and development, production, and sales, and has established a comprehensive ISO 13485 quality management system. It has been awarded the titles of "National High-tech Enterprise", "Excellent Private Enterprise in Nanjing", "Nanjing Gazelle Enterprise", and "Nanjing Recognized Enterprise Technology Center". The company currently has 50 intellectual property rights and a total of 17 II/III class products on the market and 14 III class products under development.

As the leading medical device enterprise introduced by the government of Nanjing Gaochun Development Zone, the company acquired a hundred mu of land in the development zone in 2018 to build a 100,000 square meter R&D and production base for the "Panvascular Medical Device Project". The company is committed to further developing acute and chronic coronary heart disease, prevention of cardiogenic stroke, and treatment of ischemic stroke.